Publication date: 20 March 2018
Source:Immunity, Volume 48, Issue 3
Author(s): Antonella Montinaro, Henning Walczak
Constitutively activated NF-κB signaling has long been known to be oncogenic. In this issue of Immunity, O'Reilly et al. (2018) unveil a link between loss of NF-κB1, aberrant STAT1 signaling, sterile inflammation, and the increased expression of immune checkpoint molecules as cancer drivers.
Teaser
Constitutively activated NF-κB signaling has long been known to be oncogenic. In this issue of Immunity, O'Reilly et al. (2018) unveil a link between loss of NF-κB1, aberrant STAT1 signaling, sterile inflammation, and the increased expression of immune checkpoint molecules as cancer drivers.http://ift.tt/2FPYxKi
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου